Exhaled nitric oxide is elevated in patients with progressive systemic sclerosis without interstitial lung disease

Chest

Volumn 119, Issue 5, 2001, Pages 1449-1454

  Moodley, Yuben P ^a   Lalloo, Umesh G ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

BAL; Interstitial lung disease; Nitric oxide; Systemic sclerosis

Indexed keywords

AZATHIOPRINE; BIOCHEMICAL MARKER; NITRIC OXIDE; PREDNISONE;

ADULT; ARTICLE; BLOOD CELL COUNT; BRONCHOSCOPY; CELL COMPOSITION; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; EXPIRED AIR; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; INTERSTITIAL LUNG DISEASE; LUNG LAVAGE; MALE; PNEUMONIA; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; SOUTH AFRICA; SYSTEMIC SCLEROSIS;

EID: 0034929169     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.5.1449     Document Type: Article

References (21)

1. Pulmonary organ involvement
2. The epidemiology of interstitial lung diseases
3. Structural features of interstitial lung disease in systemic sclerosis
4. Nitric oxide and lung disease
5. The biology of nitrogen oxides in the airways
6. Exhaled nitric oxide is increased in asthma
7. Increased nitric oxide in exhaled air in patients with systemic sclerosis
8. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension
9. ERS task report: Exhaled and nasal nitric oxide measurement; recommendations
10. Bronchoalveolar lavage
11. Statistical methods for assessing agreement between two methods of clinical measurement
12. Evaluation and management of scleroderma using bronchoalveolar lavage
13. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage
14. Nasally exhaled nitric oxide in humans originates mainly in the paranasal sinuses
15. Cytokines and pulmonary fibrosis
16. Fibroblast growth factors in connective tissue disease associated interstitial lung disease
17. Immunohistochemical localization of transforming growth factor b1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders
18. Multifunctional role of nitric oxide in inflammation
19. Pulmonary vascular changes in scleroderma
20. Oxidants/antioxidants in idiopathic pulmonary fibrosis
21. Increased production of the potent oxidant peroxynitrate in the lungs of patients with idiopathic pulmonary fibrosis